Heron Therapeutics, Inc. (HRTX) vs iBio, Inc. (IBIO)
A side-by-side comparison of Heron Therapeutics, Inc. and iBio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HRTX
Heron Therapeutics, Inc.
$0.34HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
IBIO
iBio, Inc.
$1.07HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
Total return — HRTX vs IBIO
growth of $100 · dividends reinvested · last 10yHRTX -97.7% (-31.4%/yr)IBIO -100.0% (-54.1%/yr)HRTX compounded faster over this window
Log scale — wide-divergence pair
HRTX IBIO
HRTX vs IBIO: by the numbers
- •IBIO is the larger company ($69M vs $64M market cap).
- •Both run net losses; HRTX's is the smaller (-22.52% vs -33044.00% net margin).
- •HRTX grew revenue faster over the past five years (12.73% vs -46.91% CAGR).
Metrics side by side
Valuation
| Metric | HRTX | IBIO |
|---|---|---|
| P/S ratio | 0.42 | 688.09 |
| P/B ratio | 10.84 | 0.80 |
Profitability
| Metric | HRTX | IBIO |
|---|---|---|
| Gross margin | 70.07% | 100.00% |
| Operating margin | -7.19% | -35141.00% |
| Net margin | -22.52% | -33044.00% |
| ROE | -492.89% | -38.55% |
| ROIC | -6.79% | -40.22% |
Growth (annualized)
| Metric | HRTX | IBIO |
|---|---|---|
| Revenue CAGR (5Y) | 12.73% | -46.91% |
| Total return CAGR (5Y) | -48.61% | -70.43% |
Frequently asked
- Which has grown faster, HRTX or IBIO?
- Over the past five years, HRTX grew revenue faster — HRTX at a 12.73% CAGR versus IBIO at -46.91%.
- How have HRTX and IBIO total returns compared?
- Over the past 10 years, HRTX delivered -31.88% and IBIO delivered -54.11% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.